ALIKO SCIENTIFIC (Ikonisys SA), Through Its Fully Owned Italian Subsidiary Hospitex International, Signs Exclusive Distribution Agreement for Italy with Menarini Diagnostics

Menarini Diagnostics Italy, part of Menarini pharmaceutical group, is the European largest IVD distribution player, with a track record and extensive experience in pathology.

The company already distributes products from leading global manufacturers in the sector. The addition of the ALIKO SCIENTIFIC business lines will further enhance Menarini’s offering, complementing its current histology solutions for anatomical pathology laboratories and thus achieving one of the most comprehensive and integrated offers in the market.

Hospitex has estimated the addressable Italian market for cytology and cell block product lines at approximately €28 million annually. Market forecasts for the FISH and immunohistochemistry segments will be developed following market entry and the collection of relevant data. The Group’s goal is to capture a significant share of the market within the first three years of commercial rollout.

Francesco Trisolini, CEO of Hospitex, commented: "This agreement with Menarini Diagnostics represents a major milestone for the Group. By partnering with the largest European IVD distributor, we are confident that our innovative solutions will reach a broader market and significantly improve diagnostic capabilities in pathological anatomy. This agreement will also fuel our R&D programs to release new breakthrough solutions for the cancer diagnostics market, such as FISH probes in a short timeframe."

Fabio Piazzalunga, Global Head of Diagnostics and General Manager of Menarini Diagnostics, added: "At Menarini, we are deeply committed to advancing oncology diagnostics, and the addition of ALIKO SCIENTIFIC’s cutting-edge technology to our portfolio aligns perfectly with our strategic vision. This collaboration will allow us to offer a more comprehensive suite of solutions to pathology professionals across Italy."